BSX vs. EW: Boston Scientific vs. Edwards Lifesciences Stock Comparison
How do Boston Scientific (BSX) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Edwards Lifesciences (EW) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | BSX | EW |
|---|---|---|
| Name | Boston Scientific Corp. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 61.96 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | EW |
|---|---|---|
| Total Return (1Y) | -55.98% | 25.08% |
| Total Return (3Y, Annualized) | -5.05% | 17.28% |
| Total Return (5Y, Annualized) | 0.57% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 25.58% |
| Beta (5Y) | 0.57 | 0.78 |
| Max Drawdown (5Y) | -61.55% | -54.32% |
| Avg. Volume (3M) | 19.73M | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | EW |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 0.81 |
| Sortino Ratio (1Y) | -1.80 | 1.23 |
Profitability
ROE (TTM)
Both Boston Scientific (BSX) at 14.12% and Edwards Lifesciences (EW) at 9.33% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Edwards Lifesciences (EW) at 15.30% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Boston Scientific (BSX) at 19.05% and Edwards Lifesciences (EW) at 30.15% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | EW |
|---|---|---|
| ROE (TTM) | 14.12% | 9.33% |
| ROA (TTM) | 5.87% | 8.77% |
| Net Margin (TTM) | 16.62% | 15.30% |
| Operating Margin (TTM) | 19.05% | 30.15% |
| Gross Margin (TTM) | 67.98% | 78.02% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and Edwards Lifesciences (EW) at 11.55% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Edwards Lifesciences (EW) at -73.74% is in the bottom quartile, showing a clear gap in earnings momentum.
Growth Metrics
| Metric | BSX | EW |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 11.55% |
| Revenue Growth (3Y CAGR) | 16.54% | 10.77% |
| EPS Growth (YoY) | 55.20% | -73.74% |
| EPS Growth (3Y CAGR) | 62.75% | -9.14% |
Financial Strength
Current Ratio (MRQ)
Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while Boston Scientific (BSX) at 0.46 runs a more typical debt-to-equity mix.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | EW |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 4.60 |
| Debt / Equity (MRQ) | 0.46 | 0.06 |
| Net Debt / EBITDA | 2.04 | -1.88 |
Dividends
Dividend Yield (TTM)
Neither Boston Scientific (BSX) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Boston Scientific (BSX) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Boston Scientific (BSX) at 2.94 is priced about in line with its industry on P/S ratio, while Edwards Lifesciences (EW) at 8.80 sits in the pricier quartile — EW costs more per dollar of sales.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Boston Scientific (BSX) at 2.42 and Edwards Lifesciences (EW) at 5.41 are valued close to their industries’ norm against book — neither stands out from peers.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | EW |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 59.38 |
| P/S Ratio (TTM) | 2.94 | 8.80 |
| P/B Ratio (MRQ) | 2.42 | 5.41 |
| Free Cash Flow Yield (TTM) | 4.02% | 1.95% |